Sensitizing HR-proficient cancers to PARP inhibitors
2017
Homologous recombination (HR) is a major DNA repair pathway that is deficient in a small subset of cancers. The best characterized of these are cancers associated with a germline or acquired mutati...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
4
Citations
NaN
KQI